Neurocrine Biosciences

Ebitda Changement Date
AbbVie USD 6.75B 433M 2023-09
Acadia Pharmaceuticals USD 36.58M 92.63M 2023-12
Agios Pharmaceuticals USD -104874000 5.6M 2023-12
ALKERMES USD 68.51M 189.7M 2023-09
Alnylam Pharmaceuticals USD -102922000 330.12M 2023-12
Amgen USD 3.66B 713M 2023-12
Cytokinetics USD -121083000 672K 2023-12
Dynavax Technologies USD -5891000 12.02M 2023-12
Exelixis USD -11287000 95.18M 2023-09
Gilead Sciences USD 2.73B 579M 2023-12
Halozyme Therapeutics USD 121.73M 10.37M 2023-12
Incyte USD 226.99M 9.73M 2023-12
Intra Cellular Therapies USD -33961000 4.38M 2023-12
Ionis Pharmaceuticals USD -2924000 137.16M 2023-12
Neurocrine Biosciences USD 146.7M 68M 2023-09
Pfizer USD 1.14B 2.05B 2023-12
Regeneron Pharmaceuticals USD 1.32B 196.8M 2023-09
Repligen USD 26.62M 25.06M 2023-12
Sarepta Therapeutics USD -9914000 112.81M 2023-09
Teva Pharmaceutical Industries USD 1.14B 13M 2023-09
Ultragenyx Pharmaceutical USD -137906000 4.69M 2023-09
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09



Neurocrine Biosciences - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.